FindOwnerSearch
Brands and Their Owners
Patent Number: 9387216
Patent Date: 2016-07-12
Patent type: utility
Described herein are methods and compositions for the treatment of prostate cancer in a subject in need thereof. The prostate cancer may be a castration resistant and an androgen receptor antagonist-resistant prostate cancer. The methods may comprise administering to the subject a CYP17-lyase inhibitor of Formula II.
Inventors
| First Name | Last Name | City | State | Country |
|---|---|---|---|---|
| Vincent O. | Njar | - | - | - |
| Douglas B. | Jacoby | - | - | - |
| Karen J. | Ferrante | - | - | - |
| Amina | Zoubeidi | - | - | - |
| Eva | Corey | - | - | - |
IPCs
| Section | Class | Sub Class | Group | Sub Group |
|---|---|---|---|---|
| A | 61 | K | 31 | 58 |
| C | 07 | J | 43 | 00 |
| C | 12 | Q | 1 | 68 |
Assignee
| Organization | First Name | Last Name | City | State | Country |
|---|---|---|---|---|---|
| University of Washington | - | - | - | - | - |
| University of Maryland, Baltimore | - | - | - | - | - |
| Thallion Pharmaceuticals Inc. | - | - | - | - | - |